These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24578935)

  • 1. Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology.
    Traczyk M; Borkowska E; Rożniecki M; Purpurowicz R; Jędrzejczyk A; Marks P; Pietrusiński M; Jabłonowski Z; Sosnowski M; Kałużewski B
    Cent European J Urol; 2012; 65(2):84-7. PubMed ID: 24578935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: a population based case-control study in China.
    Zhang Y; Jin M; Liu B; Ma X; Yao K; Li Q; Chen K
    BMC Cancer; 2008 Sep; 8():256. PubMed ID: 18783589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).
    Khan MS; Pandith AA; Ul Hussain M; Iqbal M; Khan NP; Wani KA; Masoodi SR; Mudassar S
    Tumour Biol; 2013 Feb; 34(1):521-9. PubMed ID: 23150177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HRAS T81C polymorphism modulates risk of urinary bladder cancer and predicts advanced tumors in ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Baba KM; Wani MS; Siddiqi MA
    Urol Oncol; 2013 May; 31(4):487-92. PubMed ID: 21514184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients.
    Mir R; Ah I; Javid J; Zuberi M; Guru S; Mirza M; Farooq S; Yadav P; Ray PC; Gupta N; Saxena A
    World J Oncol; 2015 Apr; 6(2):321-328. PubMed ID: 29147425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on association between an H-RAS gene polymorphism and gastric cancer development].
    Kwack KB; Song HJ; Pyun JA; Lee KJ; Cho SW
    Korean J Gastroenterol; 2010 Aug; 56(2):78-82. PubMed ID: 20729618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on association between H-ras gene polymorphism and gastric adenocarcinoma risk.
    Rostami M; Kalaei Z; Pourhoseingholi MA; Kadivar M
    Gastroenterol Hepatol Bed Bench; 2013; 6(3):146-51. PubMed ID: 24834262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer.
    Johne A; Roots I; Brockmöller J
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):68-70. PubMed ID: 12540507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M
    Tumori; 2010; 96(6):993-8. PubMed ID: 21388064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of H-ras gene point mutations in 50 cases of bladder carcinoma.
    Saito S; Hata M; Fukuyama R; Sakai K; Kudoh J; Tazaki H; Shimizu N
    Int J Urol; 1997 Mar; 4(2):178-85. PubMed ID: 9179693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of H-ras mutations in human bladder cancer detected by direct sequencing.
    Burchill SA; Neal DE; Lunec J
    Br J Urol; 1994 May; 73(5):516-21. PubMed ID: 8012773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of two novel mutations and relatively high incidence of H-RAS mutations in Vietnamese oral cancer.
    Murugan AK; Hong NT; Cuc TT; Hung NC; Munirajan AK; Ikeda MA; Tsuchida N
    Oral Oncol; 2009 Oct; 45(10):e161-6. PubMed ID: 19628422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers.
    Przybojewska B; Jagiello A; Jalmuzna P
    Cancer Genet Cytogenet; 2000 Aug; 121(1):73-7. PubMed ID: 10958945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
    Kawahara T; Kojima T; Kandori S; Kurobe M; Yoshino T; Kimura T; Nagumo Y; Ishituka R; Mitsuzuka K; Narita S; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Miyazaki J; Nishiyama H
    PLoS One; 2019; 14(8):e0220173. PubMed ID: 31369573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.
    Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC
    J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method to reveal possible ras mutations in DNA of urinary sediment cells.
    Cristaudo A; Vivaldi A; Guglielmi G; Sensales G; Ottenga F
    J Environ Pathol Toxicol Oncol; 1997; 16(2-3):201-4. PubMed ID: 9276002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-ras immunohistochemical expression and molecular analysis of urinary bladder lesions in grazing adult cattle exposed to bracken fern.
    Sardon D; de la Fuente I; Calonge E; Perez-Alenza MD; Castaño M; Dunner S; Peña L
    J Comp Pathol; 2005; 132(2-3):195-201. PubMed ID: 15737346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of CDKN2A gene A148T variant in patients with bladder cancer.
    Borkowska E; Jędrzejczyk A; Kruk A; Pietrusiński M; Traczyk M; Rożniecki M; Kałużewski B
    Cent European J Urol; 2011; 64(3):168-74. PubMed ID: 24578887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.